8-47778614-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_006904.7(PRKDC):​c.11698C>G​(p.Leu3900Val) variant causes a missense change. The variant allele was found at a frequency of 0.000764 in 1,613,794 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L3900L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00057 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 1 hom. )

Consequence

PRKDC
NM_006904.7 missense

Scores

1
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 4.66

Publications

4 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22651342).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKDCNM_006904.7 linkc.11698C>G p.Leu3900Val missense_variant Exon 83 of 86 ENST00000314191.7 NP_008835.5 P78527-1
PRKDCNM_001081640.2 linkc.11605C>G p.Leu3869Val missense_variant Exon 82 of 85 NP_001075109.1 P78527-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKDCENST00000314191.7 linkc.11698C>G p.Leu3900Val missense_variant Exon 83 of 86 1 NM_006904.7 ENSP00000313420.3 P78527-1

Frequencies

GnomAD3 genomes
AF:
0.000571
AC:
87
AN:
152244
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000823
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000608
AC:
151
AN:
248328
AF XY:
0.000601
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000204
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00103
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.000784
AC:
1146
AN:
1461432
Hom.:
1
Cov.:
31
AF XY:
0.000780
AC XY:
567
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.000291
AC:
13
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.000996
AC:
26
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
86194
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53388
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.000902
AC:
1003
AN:
1111754
Other (OTH)
AF:
0.00106
AC:
64
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
74
149
223
298
372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000571
AC:
87
AN:
152362
Hom.:
1
Cov.:
32
AF XY:
0.000671
AC XY:
50
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41584
American (AMR)
AF:
0.000588
AC:
9
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000823
AC:
56
AN:
68040
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00110
Hom.:
0
Bravo
AF:
0.000540
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000250
AC:
1
ESP6500EA
AF:
0.000841
AC:
7
ExAC
AF:
0.000662
AC:
80
EpiCase
AF:
0.00164
EpiControl
AF:
0.00137

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Severe combined immunodeficiency due to DNA-PKcs deficiency Uncertain:2
Mar 04, 2021
New York Genome Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3900 of the PRKDC protein (p.Leu3900Val). This variant is present in population databases (rs201214138, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with common variable immunodeficiency (CVID) (PMID: 26122175). ClinVar contains an entry for this variant (Variation ID: 581148). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PRKDC protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Feb 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PRKDC c.11695C>G (p.Leu3899Val), also referred to as c.11698C>G (p.Leu3900Val), results in a conservative amino acid change located in the phosphatidylinositol 3-/4-kinase, catalytic domain (IPR000403) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00061 in 248328 control chromosomes, predominantly at a frequency of 0.001 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 3-fold of the estimated maximal expected allele frequency for a pathogenic variant in PRKDC causing Severe Combined Immunodeficiency phenotype (0.00035), suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.11695C>G has been reported in the literature in the heterozygous state in one individual affected with Common Variable Immunodeficiency Disorder (van Schouwenburg_2015). This report does not provide unequivocal conclusions about association of the variant with Severe Combined Immunodeficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T;.
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.066
D
MetaRNN
Benign
0.23
T;T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Benign
2.0
M;.
PhyloP100
4.7
PrimateAI
Uncertain
0.56
T
REVEL
Uncertain
0.51
Sift4G
Uncertain
0.0090
D;D
Polyphen
0.97
D;.
Vest4
0.68
MVP
0.63
MPC
0.69
ClinPred
0.18
T
GERP RS
5.5
PromoterAI
-0.021
Neutral
Varity_R
0.38
gMVP
0.72
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201214138; hg19: chr8-48691175; COSMIC: COSV104628636; API